Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

About a third of Cuban adults have hypertension but most are under-treated leading to excess cardiovascular mortality, a new study in the Lancet Public Health has shown.

The Cuban health system’s focus on primary health care and preventative medicine has delivered substantial reductions in child and infant mortality, but premature death from the chronic disease of middle age remains high. Hypertension control in primary care has been given priority as a cost-effective means of addressing premature cardiovascular mortality in Cuba. However, there is little evidence from large-scale studies on the prevalence and management of hypertension in the country, and no direct evidence of the expected benefit of such efforts on cardiovascular mortality.

Researchers conducted a large prospective study of 150,000 adults, established by Dr Alfredo Dueñas Herrera in the late 1990s in collaboration with CTSU. A subset of participants were resurveyed in 2006-08 and all were followed up for mortality until 2016.

The study found that about a third of people in the study had hypertension, of whom two thirds had been previously diagnosed. Just over three quarters of those with diagnosed hypertension were being treated, the majority with only one hypertension medication. However, blood pressure was controlled in just a third of those receiving treatment. Uncontrolled hypertension was associated with an approximate doubling in risk of cardiovascular death and accounted for around 20% of premature cardiovascular deaths.

Professor Sarah Lewington said that although levels of hypertension diagnosis and treatment were comparable to those in some high-income countries, the proportion of people whose blood pressure was controlled was low. The under-treatment of hypertension might in part reflect the limited availability of blood pressure lowering medication, indeed the baseline survey was conducted immediately following a time of economic crisis in Cuba that began in 1991.

“As well as reducing hypertension prevalence, public health programmes in Cuba should aim to monitor and improve blood pressure control in people with diagnosed hypertension to prevent premature cardiovascular deaths”, said Dr Ben Lacey a public health consultant and co-author of the paper.

 

 

 

 

 

Similar stories

The effect of nuclear pH on cardiac gene expression

Research led by Dr Alzbeta Hulikova and Professor Pawel Swietach has, for the first time, described the potential regulation of nuclear acid-base chemistry in neonatal and adult cardiomyocytes, and explained its relevance in the context of heart physiology and pathology.

Study indicates reasons for decline in death rates from heart attacks

A new study involving Oxford Population Health researchers finds that both prevention and improved treatments have helped reduce deaths from heart attacks - but the relative importance of each varies by country, age and sex.

Review highlights impact of Long COVID on cardiovascular system

The wide-ranging effects of Long COVID and the associated issues for healthcare providers have been revealed in a new review of the major studies into the condition, which specifically highlights the impact of Long COVID on the cardiovascular system.

Commercial development of therapeutic anti-inflammatory peptide begins

An Oxford BHF CRE “Pump Priming” award to Professor Shoumo Bhattacharya and his research group led to a great return on investment with this exclusive licensing agreement for their innovative research.

London Marathon to fund De Val and Vieira Lab research as two of eight handpicked BHF projects

Two projects aimed at tackling heart failure led by Associate Professor Sarah De Val and Dr Joaquim Vieira are to be funded by the 2022 TCS London Marathon with the British Heart Foundation as its Charity of the Year. The BHF’s runners, who are raising £3 million in funding, will include De Val Lab postdoctoral researcher Dr Alice Neal.

Dr Qiang Zhang wins Society for Cardiovascular Magnetic Resonance Early Career Award 2022

Many congratulations to Dr Qiang Zhang, Oxford BHF CRE Transition Fellow, who has won a prestigious award for his work in developing a groundbreaking technology for detecting scar in the myocardium